Care Rating
Revenue of ₹280 Cr in FY2021.
Data-driven analysis for 403+ Indian stocks
Revenue of ₹280 Cr in FY2021.
Revenue of ₹3,349 Cr in FY2024.
Revenue grew 15.6% to ₹10,838 Cr in FY2025.
Revenue of ₹7,457 Cr in FY2025.
Trades at a PE of 10.4.
Revenue of ₹13,113 Cr in FY2025.
Revenue of ₹14,233 Cr in FY2025.
Revenue grew 23.7% to ₹3,746 Cr in FY2025.
Trades at a PE of 7.0.
Revenue of ₹12,883 Cr in FY2025.
Revenue of ₹74.4 Cr in FY2025.
Revenue grew 16.8% to ₹10,274 Cr in FY2025.
Revenue grew 23.7% to ₹7,221 Cr in FY2025.
Revenue declined 16.4% to ₹1,568 Cr in FY2025.
Revenue grew 18.7% to ₹9,712 Cr in FY2025.
Revenue grew 29.3% to ₹8,996 Cr in FY2025.
Revenue of ₹2,461 Cr in FY2025.
Revenue grew 16.7% to ₹33,741 Cr in FY2025.
Revenue of ₹31,609 Cr in FY2025.
Revenue grew 70.6% to ₹164 Cr in FY2025.
Revenue grew 15.4% to ₹3,452 Cr in FY2025.
Revenue of ₹9,081 Cr in FY2025.
Revenue of ₹20,175 Cr in FY2025.
Revenue of ₹3,877 Cr in FY2025.
Use our fundamental analysis tools and financial data to make informed investment decisions.